In This Section

Home / Learn / Cancer Types / Breast Cancer

Breast Cancer

Breast cancer accounts for approximately 30 percent of all new cancers in the United States. Estimates show 288,000 new cases of invasive breast cancer will be diagnosed annually. Risk for breast cancer increases with age, but is also dependent on other factors such as genetic mutations, health history, etc. Breast cancer variations also occur depending on race and ethnicity.

Advances in early detection and treatment have helped to reduce breast cancer mortality, however disparities remain among cancer patients. ACCC education programs examine the latest multidisciplinary education and resources regarding health disparities in breast cancer care, the latest clinical advances, and initiatives that aim to improve the quality of breast cancer patient care.

While breast cancer is a high-profile disease, receiving significant private and public research funding and focused awareness and prevention initiatives, patients with metastatic breast cancer face unique challenges.

ACCC supports multidisciplinary breast cancer care teams with education and resources in areas such as HR+, HER2-, HER2+, Triple Negative, and BRCA testing.

Access ACCC resources to address barriers to supportive oncology services for underserved populations with breast cancer.

On-Demand Webinars

All On-Demand Webinars

Member Spotlight

Read how these ACCC Cancer Program Members have developed innovative programs to provide efficient, quality care to their patients with breast cancer.

From the ACCCBuzz Blog

ACCC Recognizes Breast Cancer Awareness Month
October 25, 2023
A Model for Demonstrating Sustainable Outreach for Cancer Screening
August 24, 2023
Better Supporting Patients with HR+, HER2- Breast Cancer
November 02, 2022

Abstracts & Presentations

All Breast Cancer Abstracts

Cancer Buzz Podcasts

Improving Care Delivery to Patients Newly Diagnosed with Breast Cancer – [Podcast] Ep 151 May 3, 2024

Addressing this issue required a coordinated, multidisciplinary approach that involved engaging the cancer center leadership across 3 treatment departments—medical, radiation, and surgical oncology—administration, physicians, advanced practice providers (APPs), patient navigation, genetic counseling, scheduling, imaging, lab, and pathology. The primary goals of the initiative were to transform patient experience and improve timeliness to care for every newly diagnosed patient.
A New Registry Study for a Rare Form of Breast Cancer — [PODCAST] EP 116 Jun 15, 2023
Working under the hypothesis that a subset of de novo oligometastatic breast cancer patients who are treated with a combination of systemic therapy, surgery, and radiation or ablation of metastatic sites will have long-term distant metastasis free and overall survival, this multi-cohort, prospective, nationwide registry study will enroll newly diagnosed oligometastatic HER2+ breast cancer patients.
Financial Barriers to Oral Cancer Therapies — [Vodcast] Ep 19 Oct 19, 2022

Tune-in as our expert discusses how and when to screen patients, and then connect them to available resources to better support patients’ financial needs.

Hear More Podcasts

From Oncology Issues

Carrie's TOUCH: Supporting Black Women with Breast Cancer
Maddelynne Parker and Tammie Denyse, M. DIV., MCL

With disparate breast cancer outcomes, lack of messages of hope, and limited available support for Black women, Rev. Tammie and her late sister were inspired to co-found Carrie’s TOUCH in 2006.
Empowering Cancer Patients Using Integrative Medicine: A Novel Model for Breast Cancer Risk Modification
Christina M. Bowen, MD; Robin Hearne, MS, RN; Caroline Dixon; and Charles H. Shelton, MD

As a CoC-accredited critical access hospital—one of only about a dozen nationwide—The Outter Banks Hospital has developed a quality program with a focus on removing rurally linked barriers to care.
Engaging the Community to Improve Patient-Centered Care for Inflammatory Breast Cancer
Gayathri R. Devi, PhD, et al.

Through a community engagement session and focused interviews, researchers from Duke University School of Medicine, N.C., held a consortium to help stakeholders identify barriers to inflammatory breast cancer awareness, diagnosis, and appropriate treatment. Today the Duke Consortium for Inflammatory Breast Cancer is committed to translating research into action.

Share